On May 28, 2020, the Jenner Institute, University of Oxford, UK and Advent Srl ﾖ an IRBM company, Pomezia,Italy announced a new agreement to develop a novel vaccine for coronavirus. The Jenner Institute at the University of Oxford has agreed a contract with Advent Srl to produce the first batch of the novel coronavirus vaccine ChAdOx1 nCoV-19 for clinical testing.

The vaccine ﾑseed stockﾒ is currently being produced at the Universityﾒs Clinical Biomanufacturing Facility, and will be transferred to Advent who will initially produce 1000 doses for the first clinical trials of this vaccine.